JP2007517783A5 - - Google Patents

Download PDF

Info

Publication number
JP2007517783A5
JP2007517783A5 JP2006545583A JP2006545583A JP2007517783A5 JP 2007517783 A5 JP2007517783 A5 JP 2007517783A5 JP 2006545583 A JP2006545583 A JP 2006545583A JP 2006545583 A JP2006545583 A JP 2006545583A JP 2007517783 A5 JP2007517783 A5 JP 2007517783A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006545583A
Other languages
Japanese (ja)
Other versions
JP5546717B2 (ja
JP2007517783A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/042976 external-priority patent/WO2005058835A2/en
Publication of JP2007517783A publication Critical patent/JP2007517783A/ja
Publication of JP2007517783A5 publication Critical patent/JP2007517783A5/ja
Application granted granted Critical
Publication of JP5546717B2 publication Critical patent/JP5546717B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2006545583A 2003-12-16 2004-12-16 アリピプラゾール結晶質形態を調製する方法 Expired - Lifetime JP5546717B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US53029703P 2003-12-16 2003-12-16
US60/530,297 2003-12-16
US53383103P 2003-12-30 2003-12-30
US60/533,831 2003-12-30
US61840404P 2004-10-13 2004-10-13
US60/618,404 2004-10-13
US61896004P 2004-10-14 2004-10-14
US60/618,960 2004-10-14
PCT/US2004/042976 WO2005058835A2 (en) 2003-12-16 2004-12-16 Methods of preparing aripiprazole crystalline forms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013147411A Division JP2013237682A (ja) 2003-12-16 2013-07-16 アリピプラゾール結晶質形態を調製する方法

Publications (3)

Publication Number Publication Date
JP2007517783A JP2007517783A (ja) 2007-07-05
JP2007517783A5 true JP2007517783A5 (enExample) 2008-04-17
JP5546717B2 JP5546717B2 (ja) 2014-07-09

Family

ID=34705304

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006545583A Expired - Lifetime JP5546717B2 (ja) 2003-12-16 2004-12-16 アリピプラゾール結晶質形態を調製する方法
JP2013147411A Pending JP2013237682A (ja) 2003-12-16 2013-07-16 アリピプラゾール結晶質形態を調製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013147411A Pending JP2013237682A (ja) 2003-12-16 2013-07-16 アリピプラゾール結晶質形態を調製する方法

Country Status (11)

Country Link
US (2) US7504504B2 (enExample)
EP (1) EP1613598B1 (enExample)
JP (2) JP5546717B2 (enExample)
AT (1) ATE529409T1 (enExample)
CA (1) CA2550726A1 (enExample)
ES (1) ES2374922T3 (enExample)
IL (1) IL175512A (enExample)
PL (1) PL1613598T3 (enExample)
PT (1) PT1613598E (enExample)
TW (1) TW200529850A (enExample)
WO (1) WO2005058835A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009990A1 (en) * 2003-07-25 2005-02-03 Hetero Drugs Limited Aripiprazole crystalline forms
US7714129B2 (en) * 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
US7893261B2 (en) 2004-03-26 2011-02-22 Baylor University Serotonin reuptake inhibitors
EP1797039A1 (en) 2004-09-13 2007-06-20 Matrix Laboratories Ltd Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts
CN101111481A (zh) * 2004-11-18 2008-01-23 斯索恩有限公司 制备结晶阿立哌唑的方法
WO2006053780A1 (en) 2004-11-18 2006-05-26 Synthon B.V. Crystalline aripiprazole solvates
EP1686117A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Polymorph and solvates of aripiprazole
AU2006224759A1 (en) † 2005-03-17 2006-09-21 Synthon B.V. Process of making crystalline Type II aripiprazole
CA2600542A1 (en) 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
CA2605128A1 (en) * 2005-04-15 2007-01-11 Medichem, S.A. Syntheses and preparations of polymorphs of crystalline aripiprazole
BRPI0606163A2 (pt) * 2005-09-29 2009-05-26 Teva Pharma métodos para preparar aripiprazola anidra forma ii
EP1919453A2 (en) * 2005-12-22 2008-05-14 Teva Pharmaceutical Industries Ltd Processes for reducing particle size of aripiprazole
PT1808165E (pt) * 2006-01-05 2009-06-09 Teva Pharma Formulações secas de aripiprazole
DE602006004694D1 (de) * 2006-01-05 2009-02-26 Teva Pharma Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
US7799790B2 (en) 2006-07-20 2010-09-21 Helm Ag Amorphous aripiprazole and process for the preparation thereof
WO2008020453A2 (en) * 2006-08-17 2008-02-21 Unichem Laboratories Limited A process for the preparation of a novel crystalline polymorph of aripiprazole
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
WO2008051541A2 (en) * 2006-10-24 2008-05-02 Cambrex Charles City, Inc. Process for preparing anhydrous aripirazole type i
PT2082735E (pt) 2008-01-23 2010-10-12 Helm Ag Aripripazole amorfo e processo para a sua preparação
EP2238976B1 (en) 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
CN101948426A (zh) * 2010-09-13 2011-01-19 浙江华海药业股份有限公司 一种制备阿立哌唑晶型b的新方法
CA2816203C (en) * 2010-10-28 2017-02-21 Transdermal Research Pharm Laboratories, Llc Aripiprazole compositions and methods for its transdermal delivery
US9757374B2 (en) 2010-10-28 2017-09-12 Aequus Pharmaceuticals Inc. Aripiprazole compositions and methods for its transdermal delivery
WO2012077134A1 (en) * 2010-12-07 2012-06-14 Ind-Swift Laboratories Limted Process for preparing aripiprazole polymorphs
KR101340214B1 (ko) * 2011-03-31 2013-12-10 주식회사 대웅제약 무수 아리피프라졸 ⅱ형 결정의 제조방법
CN102850268B (zh) * 2011-06-27 2015-07-15 上海中西制药有限公司 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
KR101372840B1 (ko) * 2012-08-02 2014-03-12 주식회사 에스텍파마 무수 아리피프라졸 결정의 제조방법
EP3065700A1 (en) 2013-11-07 2016-09-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole
SG10202012791TA (en) 2013-11-15 2021-01-28 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
CN106474058B (zh) 2015-08-31 2020-01-07 南京诺瑞特医药科技有限公司 具有延长的保质期的阿立哌唑可注射悬浮液制剂
TWI665194B (zh) * 2016-02-19 2019-07-11 諾瑞特國際藥業股份有限公司 阿立哌唑的新晶型

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JP2608788B2 (ja) 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
ES2078447T3 (es) 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
US6221153B1 (en) 1998-06-09 2001-04-24 Trevor Percival Castor Method for producing large crystals of complex molecules
US6525201B2 (en) 2000-03-20 2003-02-25 Teva Pharmaceutical Industries, Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
UA79984C2 (en) * 2002-08-20 2007-08-10 Bristol Myers Squibb Co Preparation on the basis of aripiprazole complex and use thereof
DK1480953T4 (da) 2003-01-09 2010-11-15 Otsuka Pharma Co Ltd Fremgangsmåde til fremstilling af aripiprazol
WO2004083183A1 (en) * 2003-03-21 2004-09-30 Hetero Drugs Limited Novel crystalline forms of aripiprazole
EP1618103A2 (en) * 2003-04-25 2006-01-25 Cadila Healthcare Ltd. Polymorphs of aripiprazole
CA2428237C (en) 2003-05-08 2010-07-20 Delmar Chemicals Inc. Process for the preparation of carbostyril derivatives
WO2005009990A1 (en) 2003-07-25 2005-02-03 Hetero Drugs Limited Aripiprazole crystalline forms
US7166418B2 (en) 2003-09-03 2007-01-23 Matsushita Electric Industrial Co., Ltd. Sulfonamide compound, polymer compound, resist material and pattern formation method
TWI371274B (en) 2003-10-23 2012-09-01 Bristol Myers Squibb Co Process for making sterile aripiprazole of desired mean particle size
US20050277650A1 (en) 2004-04-20 2005-12-15 Sundaram Venkataraman Process for preparing aripirazole hydrate
US7507823B2 (en) * 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
WO2006012237A2 (en) 2004-06-25 2006-02-02 Shanghai Institute Of Pharmaceutical Industry Aripiprazole crystaline forms and associated methods
EP1797039A1 (en) 2004-09-13 2007-06-20 Matrix Laboratories Ltd Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts
DE102005048695A1 (de) * 2004-10-12 2006-05-18 Chemagis Ltd. Verfahren zur Herstellung und Reinigung von Carbostyrilverbindungen wie beispielsweise Aripiprazol und 7-(4-Halobutoxy)-3,4-dihydro-2(1H)-quinolinonen
US20060079690A1 (en) 2004-10-12 2006-04-13 Vladimir Naddaka Processes for preparing 7-hydroxy-3,4-dihydro-2(1H)-quinolinone and the use in aripiprazole preparation thereof
WO2006053780A1 (en) * 2004-11-18 2006-05-26 Synthon B.V. Crystalline aripiprazole solvates
CN101111481A (zh) * 2004-11-18 2008-01-23 斯索恩有限公司 制备结晶阿立哌唑的方法
EP1686117A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Polymorph and solvates of aripiprazole
EP1933814A2 (en) * 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
EP1919453A2 (en) * 2005-12-22 2008-05-14 Teva Pharmaceutical Industries Ltd Processes for reducing particle size of aripiprazole
US20070213535A1 (en) * 2006-03-07 2007-09-13 Chemagis Ltd. Process for the manufacture of aripiprazole by using purified carbostyril compounds such as 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
US20060223820A1 (en) * 2006-03-21 2006-10-05 Chemagis Ltd. Crystalline aripiprazole salts and processes for preparation and purification thereof
WO2007113846A1 (en) * 2006-04-03 2007-10-11 Alembic Limited A process for the preparation of aripiprazole
US20070238876A1 (en) * 2006-04-10 2007-10-11 Neera Tewari Process for the preparation of aripiprazole
EP1880714A1 (en) * 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2022C549I2 (enExample)
BE2021C001I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2018C045I2 (enExample)
BE2020C525I2 (enExample)
BE2017C063I2 (enExample)
BE2017C027I2 (enExample)
BE2017C023I2 (enExample)
BE2017C002I2 (enExample)
BE2016C067I2 (enExample)
BE2016C014I2 (enExample)
BE2015C041I2 (enExample)
BE2015C038I2 (enExample)
BE2015C014I2 (enExample)
BE2014C071I2 (enExample)
BE2015C015I2 (enExample)
BE2014C064I2 (enExample)
BE2014C063I2 (enExample)